bioRxivCancer Biology
Dynamic 3D chromosomal landscapes in acute leukemia
A. Kloetgen, P. Thandapani, P. Ntziachristos, Y. Ghebrechristos, S. Nomikou, C. Lazaris, X. Chen, H. Hu, S. Bakogianni, J. Wang, Y. Fu, F. Boccalatte, H. Zhong, E. Paietta, T. Trimarchi, Y. Zhu, P. van Vlierberghe, G. G. Inghirami, T. Lionnet, I. Aifantis, A. Tsirigos
Abstract
Three-dimensional (3D) chromatin architectural changes can alter the integrity of topologically associated domains (TADs) and rewire specific enhancer-promoter interactions impacting gene expression. Recently, such alterations have been implicated in human disease, highlighting the need for a deeper understanding of their role. Here, we investigate the reorganization of chromatin architecture in T cell acute lymphoblastic leukemia (T-ALL) using primary human leukemia specimens and its dynamic responses to pharmacological agents. Systematic integration of matched in situ Hi-C, RNA-Seq and CTCF ChIP-Seq datasets revealed widespread changes in intra-TAD chromatin interactions and TAD boundary insulation in T-ALL. Our studies identify and focus on a TAD \"fusion\" event being associated with loss of CTCF-mediated insulation, enabling direct interactions between the MYC promoter and a distal super-enhancer. Moreover, our data show that small molecule inhibitors targeting either oncogenic signal transduction or epigenetic regulation reduce specific 3D interactions associated with transformation. Overall, our study highlights the impact, complexity and dynamic nature of 3D chromatin architecture in human acute leukemia.\n\nOne Sentence Summary3D chromatin alterations in T cell leukemia are accompanied by changes in insulation and oncogene expression and can be partially restored by targeted drug treatments.
- organism: human
- assay: Hi-C
- assay: bulk RNA-seq
- assay: ChIP-seq
- research focus: chromatin & epigenetic regulation
- research focus: drug response / drug discovery
- research focus: cell type annotation
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TCF3::HLF Orchestrates an Enhancer-Promoter Network with Activation of MEF2C to Promote Immature HSC gene Expression in Leukemia
Valdemar Priebe, Bartimée Galvan, … Jean‐Pierre Bourquin·Science AdvancesPeer-reviewed·May 6, 2026
- 3D Genome Analysis Identifies Enhancer Hijacking Mechanism for High-Risk Factors in Human T-Lineage Acute Lymphoblastic Leukemia
Lu Yang, Fengling Chen, … Hong Wu·bioRxiv·Mar 11, 2020
- Three-dimensional chromatin landscapes in MLLr AML
Pinpin Sui, Zhihong Wang, … Feng Pan·Experimental Hematology and OncologyPeer-reviewed·May 22, 2024
- The 3D genome of pediatric B-cell precursor acute lymphoblastic leukemia
Larissa Helena Moura‐Castro, Efe Aydın, … Kajsa M. Paulsson·bioRxiv·Jul 22, 2025
- Targeting H3K4 methylation as a novel therapeutic strategy against tumor infiltration and nuclear changes of acute lymphoblastic leukemia cells.
R. Gonzalez-Novo, A. De Lope, … J. Redondo-Munoz·bioRxiv·Jun 16, 2022
- Targeting the 3D genome by anthracyclines for chemotherapeutic effects
Minkang Tan, Shengnan Sun, … Baoxu Pang·Proceedings of the National Academy of SciencesPeer-reviewed·Oct 3, 2025